Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuhiro Tanaka

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Nature Reviews. Nephrology|March 6, 2013
Angiogenesis and hypoxia in the kidneyTetsuhiro Tanaka, Masaomi Nangaku
Kidney International|May 3, 2014
ANO1: an additional key player in cyst growthTetsuhiro Tanaka, Masaomi Nangaku
Seminars in Nephrology|May 14, 2018
HIF Activation Against CVD in CKD: Novel Treatment OpportunitiesTetsuhiro Tanaka, Kai-Uwe Eckardt
Kidney360|April 4, 2022
Hypoxia-Inducible Factor and Oxygen Biology in the KidneyMai Sugahara, Tetsuhiro Tanaka, Masaomi Nangaku
Kidney Diseases (Basel, Switzerland)|August 19, 2016
Hypoxia and Dysregulated Angiogenesis in Kidney DiseaseShinji Tanaka, Tetsuhiro Tanaka, Masaomi Nangaku
Pharmacology & Therapeutics|August 28, 2022
Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitorsMai Sugahara, Tetsuhiro Tanaka, Masaomi Nangaku
Nephron|September 19, 2015
How the Target Hemoglobin of Renal Anemia Should BeImari Mimura, Tetsuhiro Tanaka, Masaomi Nangaku
Journal of Diabetes Investigation|January 19, 2017
Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney diseaseYosuke Hirakawa, Tetsuhiro Tanaka, Masaomi Nangaku
Antioxidants (Basel, Switzerland)|August 6, 2021
Metabolic Changes and Oxidative Stress in Diabetic Kidney DiseaseMidori Sakashita, Tetsuhiro Tanaka, Reiko Inagi
Current Opinion in Nephrology and Hypertension|July 9, 2011
The role of incretins in salt-sensitive hypertension: the potential use of dipeptidyl peptidase-IV inhibitorsTetsuhiro Tanaka, Masaomi Nangaku, Akira Nishiyama
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Nature Reviews. Nephrology|March 6, 2013
Angiogenesis and hypoxia in the kidneyTetsuhiro Tanaka, Masaomi Nangaku
Kidney International|May 3, 2014
ANO1: an additional key player in cyst growthTetsuhiro Tanaka, Masaomi Nangaku
Seminars in Nephrology|May 14, 2018
HIF Activation Against CVD in CKD: Novel Treatment OpportunitiesTetsuhiro Tanaka, Kai-Uwe Eckardt
Kidney360|April 4, 2022
Hypoxia-Inducible Factor and Oxygen Biology in the KidneyMai Sugahara, Tetsuhiro Tanaka, Masaomi Nangaku
Kidney Diseases (Basel, Switzerland)|August 19, 2016
Hypoxia and Dysregulated Angiogenesis in Kidney DiseaseShinji Tanaka, Tetsuhiro Tanaka, Masaomi Nangaku
Pharmacology & Therapeutics|August 28, 2022
Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitorsMai Sugahara, Tetsuhiro Tanaka, Masaomi Nangaku
Nephron|September 19, 2015
How the Target Hemoglobin of Renal Anemia Should BeImari Mimura, Tetsuhiro Tanaka, Masaomi Nangaku
Journal of Diabetes Investigation|January 19, 2017
Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney diseaseYosuke Hirakawa, Tetsuhiro Tanaka, Masaomi Nangaku
Antioxidants (Basel, Switzerland)|August 6, 2021
Metabolic Changes and Oxidative Stress in Diabetic Kidney DiseaseMidori Sakashita, Tetsuhiro Tanaka, Reiko Inagi
Current Opinion in Nephrology and Hypertension|July 9, 2011
The role of incretins in salt-sensitive hypertension: the potential use of dipeptidyl peptidase-IV inhibitorsTetsuhiro Tanaka, Masaomi Nangaku, Akira Nishiyama
Pageof 15